Package Leaflet: Information for the Patient
Rabeprazole Kern Pharma 20 mg Gastro-Resistant Tablets EFG
Rabeprazole Sodium
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Rabeprazole Kern Pharma contains the active substance rabeprazole sodium. It belongs to a group of medicines called “Proton Pump Inhibitors” (PPIs).
These work by reducing the amount of acid produced by the stomach.
Rabeprazole Kern Pharma tablets are used to treat the following conditions:
You should consult your doctor if you do not feel better or worsen.
Do not take Rabeprazole Kern Pharma:
Do not use rabeprazole if you are in any of the above situations. If you are not sure, talk to your doctor or pharmacist before using rabeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Rabeprazole Kern Pharma.
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before using rabeprazole.
Children
Rabeprazole Kern Pharma is not recommended for children.
.
Taking a proton pump inhibitor like Rabeprazole, especially over a period of more than one year, may slightly increase your risk of fracture of the hip, wrist or spine. Consult your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
Taking Rabeprazole Kern Pharma with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you have bought without a prescription, including herbal medicines.
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before using rabeprazole.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
You may feel drowsy while taking rabeprazole. If this happens, do not drive or use tools or machines.
Rabeprazole Kern Pharma 20 mg gastro-resistant tablets contain sodium:
This medicine contains less than 1 mmol sodium (23 mg) per tablet, i.e., essentially “sodium-free”.
Follow the instructions for administration of this medicine exactly as told by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking this medicine
Adults and the elderly:
The following doses are usually recommended for adults and the elderly. Do not change the dose or duration of treatment yourself.
For "gastro-oesophageal reflux disease" (GORD)
Treatment of moderate to severe symptoms (symptomatic GORD)
Treatment of more severe symptoms (erosive or ulcerative GORD)
Long-term treatment of symptoms (maintenance of GORD)
For stomach ulcers (peptic ulcers)
For duodenal ulcers
For ulcers caused by H. Pylori infection and to stop them coming back
For more information on the other medicines used to treat H. Pylori, see the individual package leaflets.
Zollinger-Ellison syndrome where the stomach produces too much acid
If you are on long-term treatment, you will need to go for regular check-ups with your doctor to review your tablets and symptoms.
Patients with liver problems. You should consult your doctor, who will take special care when starting treatment with rabeprazole and while you are being treated with rabeprazole.
If you take more Rabeprazole Kern Pharma than you should
Do not take more tablets per day than prescribed. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20 (indicating the medicine and the amount taken).
If you forget to take Rabeprazole Kern Pharma
If you forget to take a tablet, take one as soon as you remember and then continue as normal. However, if it is almost time for your next dose, skip the missed tablet and continue as usual.
If you forget to take your medicine for more than 5 days, call your doctor before taking any more medicine.
Do not take a double dose (two tablets at the same time) to make up for missed doses.
If you stop taking Rabeprazole Kern Pharma
Relief of symptoms will usually occur before the ulcer has healed completely. It is important that you do not stop taking the tablets until your doctor tells you to.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects are usually mild and improve without you having to stop taking this medicine.
Stop taking rabeprazole and see a doctor immediately if you notice any of the following serious side effects; you may need urgent medical attention:
These side effects are rare(may affect up to 1 in 1,000 people):
Other possible side effects:
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Changes in how your liver is working (shown in blood tests).
Rare side effects(may affect up to 1 in 1,000 people):
Reduction in the number of blood platelets, which can result in bleeding or bruising more easily than normal.
Frequency not known(frequency cannot be estimated from the available data)
Do not worry about this list of side effects. You may not get any of them.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.
Do not store above 25°C. Store in the original package.
Do not use this medicine if you notice the packaging is damaged or shows signs of tampering.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Rabeprazol Kern Pharma
The active ingredient is sodium rabeprazole.
Each Rabeprazol Kern Pharma 20 mg gastro-resistant tablet contains 20 mg of sodium rabeprazole, equivalent to 18.85 mg of rabeprazole.
The other components are:
Core of the tablet:mannitol (E421), heavy magnesium oxide (E530), hydroxypropylcellulose (E463), magnesium stearate (E572).
Subcoating:ethylcellulose (E462), heavy magnesium oxide (E530).
Enteric coating:hypromellose phthalate, dibutyl sebacate, yellow iron oxide (E172), titanium dioxide (E171), talc.
Appearance of the Product and Container Content
Gastro-resistant (coated) tablets of yellow color, biconvex.
The containers contain aluminum blister strips of 1, 5, 7, 14, 15, 25, 28, 30, 50, 56, 75, 98, and 120 tablets.
Not all presentations may be marketed.
Marketing Authorization Holder:
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Manufacturer:
Laboratorios LICONSA, S.A.
Avda. Miralcampo, Nº7, Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Denmark: | Ralic 10 mg enteric-coated tablet Ralic 20 mg enteric-coated tablet |
Greece: | Aircodos 10 mg enteric-coated tablet Aircodos 20 mg enteric-coated tablet |
Spain: | Rabeprazol Kern Pharma 10 mg gastro-resistant tablets EFG Rabeprazol Kern Pharma 20 mg gastro-resistant tablets EFG |
Hungary: | Ralic 10 mg gastro-resistant tablet Ralic 20 mg gastro-resistant tablet |
Ireland: | Razole 10 mg gastro-resistant tablets Razole 20 mg gastro-resistant tablets |
Portugal: | Ralic, 10 mg, Gastro-resistant tablet Ralic, 20 mg, Gastro-resistant tablet |
Date of the Last Revision of this Leaflet: June 2021
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of RABEPRAZOL KERN PHARMA 20 mg GASTRO-RESISTANT TABLETS in October, 2025 is around 24.37 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.